Prof. Zühal YAPICI OBUZ

Publication Network

Articles 87

1. Missense variants in PKAN: insights from a multi-patient genetic analysis

Kılıç M., Mercan S., Barut B. Ö., Demirkıran D. M., Yalçın Çakmaklı G., Akçakaya N. H., et al.

Neurogenetics , vol.26, pp.82-90, 2025 (Peer-Reviewed Journal) Sustainable Development

2. Quantitative Iron Measurements in the Basal Ganglia of NBIA Patients Using QSM: Insights From a Tertiary Center

Uygun Ö., Özcan A., Aras F. K., Bozdemir E., Uğur İşeri S., GÜLTEKİN M., et al.

Annals of Clinical and Translational Neurology , vol.12, no.11, pp.2305-2316, 2025 (SCI-Expanded, Scopus)

3. Effects of immune modulatory treatment on language and psychiatric profile in patients with electrical status epilepticus in sleep (ESES)

Emekli A. S., Dörtkol Ş. O., Savaş M., Öz F., İşcen P., Topaloğlu P., et al.

EPILEPSY & BEHAVIOR , vol.163, 2025 (SCI-Expanded)

4. Factors Associated with COVID-19 Vaccination Status in Adolescents Diagnosed With Epilepsy

MUTLU C., Taşpolat E. R., Kırışman-Keleş H., Yapıcı Z., Topaloğlu P., BODUR M.

Neuropsychiatric Investigation , vol.63, no.1, 2025 (Scopus)

5. QSM-Based Evidence of Brain Iron Accumulation in THAP1 Dystonia with Biallelic Mutation

Tarhan G., Kamaci I., Dusek P., ÇAPAN N., Sayman C., Turan C., et al.

Movement Disorders Clinical Practice , 2025 (SCI-Expanded, Scopus)

6. Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes

Berkovic S. F., Neale B. M., Zsurka G., Zizovic M., Zimprich F., Zara F., et al.

Nature Neuroscience , vol.27, no.10, pp.1864-1879, 2024 (SCI-Expanded)

7. Exome data of developmental and epileptic encephalopathy patients reveals de novo and inherited pathologic variants in epilepsy-associated genes

Çapan Ö. Y., Yapıcı Z., Özbil M., Çağlayan H. S.

Seizure , vol.116, pp.51-64, 2024 (SCI-Expanded)

8. Epilepsy in dystrophinopathies: A retrospective cohort and review of the literature

Kizek Ö., Yapıcı Z., Topaloğlu P.

Epilepsy and Behavior , vol.151, 2024 (SCI-Expanded)

9. Exploring shared triggers and potential etiopathogenesis between migraine and idiopathic/genetic epilepsy: Insights from a multicenter tertiary-based study

TÜRK B. G., Yeni S. N., Atalar A. Ç., Ekizoğlu E., Gök D. K., Baykan B., et al.

CLINICAL NEUROLOGY AND NEUROSURGERY , vol.237, 2024 (SCI-Expanded) Sustainable Development

10. Targeted resequencing reveals high-level mosaicism for a novel frameshift variant in WDR45 associated with beta-propeller protein-associated neurodegeneration

Susgun S., Demirel M., Yalçın Çakmaklı G., Salman B., Oguz K. K., Elibol B., et al.

International Journal of Neuroscience , vol.134, no.10, pp.1040-1045, 2024 (SCI-Expanded)

11. Lack of SPNS1 results in accumulation of lysolipids and lysosomal storage disease in mouse models

Ha H. T., Liu S., Nguyen X. T., Vo L. K., Leong N. C., Nguyen D. T., et al.

JCI Insight , vol.9, no.8, 2024 (SCI-Expanded)

12. GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture

Stevelink R., Campbell C., Chen S., Abou-Khalil B., Adesoji O. M., Afawi Z., et al.

Nature Genetics , vol.55, no.9, pp.1471-1482, 2023 (SCI-Expanded)

13. Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals.

Montanucci L., Collins R. L., Niestroj L., Parthasarathy S., Xian J., Ganesan S., et al.

Nature communications , vol.14, no.1, pp.4392, 2023 (SCI-Expanded)

14. Clinical and genetic analyses in syndromic intellectual disability with primary microcephaly reveal biallelic and de novo variants in patients with parental consanguinity.

Mercan S., Akcakaya N. H., Salman B., Yapici Z., Ozbek U., Ugur Iseri S. A.

Genes & genomics , vol.45, no.1, pp.13-21, 2023 (SCI-Expanded)

15. Four Turkish families with hyperekplexia: A missense mutation and the exon 1–7 deletion in the GLRA1 gene

Tezen D., Şimşir G., Çokar Ö., Demirbilek V., Başak A. N., Yapıcı Z.

Parkinsonism and Related Disorders , vol.105, pp.128-131, 2022 (SCI-Expanded)

16. MYO1H is a novel candidate gene for autosomal dominant pure hereditary spastic paraplegia

Selcuk E., Kirimtay K., Temizci İmanç B., Akarsu Ş., Everest E., Baslo M. B., et al.

MOLECULAR GENETICS AND GENOMICS , vol.297, no.4, pp.1141-1150, 2022 (SCI-Expanded)

17. Headache in idiopathic/genetic epilepsy: Cluster analysis in a large cohort

Atalar A. C., Türk B. G., Ekizoglu E., Gok D. K., Baykal B., Özge A., et al.

EPILEPSIA , vol.63, no.6, pp.1516-1529, 2022 (SCI-Expanded)

18. Novel WDR45 frameshift variant detected by whole exome sequencing in beta-propeller protein-associated neurodegeneration disease

Susgun S., Demirel M., Yalçın Çakmaklı G., Elibol B., Iseri S. U., Yapici Z.

EUROPEAN JOURNAL OF HUMAN GENETICS , vol.30, no.SUPPL 1, pp.304-305, 2022 (SCI-Expanded)

19. A case report of sudden-onset auditory neuropathy spectrum disorder associated with Brown-Vialetto-Van Laere syndrome (riboflavin transporter deficiency)

Gedik Soyuyuce O., Ayanoğlu Aksoy E., Yapici Z.

INTERNATIONAL JOURNAL OF AUDIOLOGY , vol.61, no.3, pp.258-264, 2022 (SCI-Expanded)

20. Two cases with mitochondrial membrane protein-associated neurodegeneration: genetic features and long-term clinical follow-up.

Mercan S., Ugur Iseri S. A., Yigiter R., Akcakaya N. H., Saka E., Yapici Z.

Neurocase , vol.28, no.1, pp.37-41, 2022 (SCI-Expanded)

21. A Patient with Glucose Transporter Type 1 Deficiency Syndrome: Paroxysmal Choreoathetosis and Cerebral Positron-Emission Tomography Findings

Yapici Z., Topaloglu P., Turkmen C., Eraksoy M., Zuberi S.

NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY , vol.39, no.1, pp.53-55, 2022 (SCI-Expanded)

22. Adjunctive everolimus therapy for tuberous sclerosis complex-associated refractory seizures: Results from the postextension phase of EXIST-3

Franz D. N., Lawson J. A., Yapici Z., Ikeda H., Polster T., Nabbout R., et al.

EPILEPSIA , vol.62, no.12, pp.3029-3041, 2021 (SCI-Expanded)

23. Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity

Trislan-Noguero A., Borras E., Molero-Luis M., Wassenberg T., Peters T., Verbeek M. M., et al.

MOVEMENT DISORDERS , vol.36, pp.690-703, 2021 (SCI-Expanded)

24. Novel mutations in ATP13A2 associated with mixed neurological presentations and iron toxicity due to nonsense-mediated decay

Kirimtay K., Temizci B., GÜLTEKİN M., Yapici Z., Karabay Korkmaz A.

BRAIN RESEARCH , vol.1750, 2021 (SCI-Expanded)

25. Immune alterations in subacute sclerosing panencephalitis reflect an incompetent response to eliminate the measles virus

Yentür S. P., Demirbilek V., Gurses C., Barış S., Kuru U., Ayta S., et al.

PLOS ONE , vol.16, no.1, 2021 (SCI-Expanded) Sustainable Development

26. Leukoencephalopathy With Brain Stem and Spinal Cord Involvement and Lactate Elevation (LBSL) A Case With Long-term Follow-up

Yazici Gencdal I., DİNÇER A., Obuz O., Yapici Z.

NEUROLOGIST , vol.25, no.5, pp.144-147, 2020 (SCI-Expanded)

27. Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study

Ilki C. D., Gunduz T., Kurtuncu M., Yapici Z., Sencer S., Eraksoy M.

TURKISH JOURNAL OF NEUROLOGY , vol.26, no.1, pp.34-38, 2020 (ESCI)

28. Hypermanganesemia with Dystonia 1: A Novel Mutation and Response to Iron Supplementation

Yapici Z., Tuschl K., Eraksoy M.

MOVEMENT DISORDERS CLINICAL PRACTICE , vol.7, no.1, pp.94-96, 2020 (ESCI)

29. Non-convulsive status epilepticus in two patients with tuberous sclerosis

Erdal Y., Alnak A., Oztop O., Tekturk P., Yapici Z.

CHILDS NERVOUS SYSTEM , vol.35, no.12, pp.2405-2409, 2019 (SCI-Expanded)

30. Panayiotopoulos syndrome and Gastaut syndrome are distinct entities in terms of neuropsychological findings

Kalem S. A., Elmali A. D., Demirbilek V., Oktem O., YAPICI Z., SALTIK S., et al.

EPILEPSY & BEHAVIOR , 2019 (SCI-Expanded)

31. Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study

Klopstock T., Tricta F., Neumayr L., Karin I., Zorzi G., Fradette C., et al.

LANCET NEUROLOGY , vol.18, no.7, pp.631-642, 2019 (SCI-Expanded)

32. Genotype-phenotype Correlation in Pelizaeus Merzbacher Disease and Pelizaeus Merzbacher-like Disease

Gokcal E., Bilir B., BATTALOĞLU E., Aydin R., Yapici Z.

BEZMIALEM SCIENCE , vol.7, no.3, pp.215-220, 2019 (ESCI)

33. A Novel and Mosaic WDR45 Nonsense Variant Causes Beta-Propeller Protein-Associated Neurodegeneration Identified Through Whole Exome Sequencing and X chromosome Heterozygosity Analysis.

Akcakaya N. H., Salman B., Gormez Z., Arguden Y. T., Cirakoglu A., Cakmur R., et al.

Neuromolecular medicine , vol.21, no.1, pp.54-59, 2019 (SCI-Expanded)

34. Clinical and genetic spectrum of an orphan disease MPAN: a series with new variants and a novel phenotype.

Akcakaya N. H., Haryanyan G., Mercan S., Sozer N., Ali A., Tombul T., et al.

Neurologia i neurochirurgia polska , vol.53, no.6, pp.476-483, 2019 (SCI-Expanded)

35. Correlation of Prechtl Qualitative Assessment of General Movement Analysis with Neurological Evaluation: The Importance of Inspection in Infants

Akcakaya N. H., Altunalan T., Dogan T. D., Yilmaz A., Yapici Z.

TURKISH JOURNAL OF NEUROLOGY , vol.25, no.2, pp.63-70, 2019 (ESCI)

36. Investigation of neuronal auto-antibodies in children diagnosed with epileptic encephalopathy of unknown cause

Tekturk P., Baykan B., Erdag E., Peach S., Sezgin M., Yapici Z., et al.

BRAIN & DEVELOPMENT , vol.40, no.10, pp.909-917, 2018 (SCI-Expanded)

37. Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial

Franz D. N., Lawson J. A., Yapici Z., Ikeda H., Polster T., Nabbout R., et al.

NEUROLOGY-CLINICAL PRACTICE , vol.8, no.5, pp.412-420, 2018 (ESCI) Sustainable Development

38. A new splice-site mutation in SLC12A6 causing Andermann syndrome with motor neuronopathy

Akcakaya N. H., Yapici Z., Tunca C. I., Tekturk P., Akcimen F., Basak A. N.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , vol.89, no.10, pp.1123-1125, 2018 (SCI-Expanded)

39. DBS in pediatric patients: institutional experience

Canaz H., Karalok I., Topcular B., Agaoglu M., Yapici Z., Aydin S.

CHILDS NERVOUS SYSTEM , vol.34, no.9, pp.1771-1776, 2018 (SCI-Expanded)

40. Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial

Curatolo P., Franz D. N., Lawson J. A., Yapici Z., Ikeda H., Polster T., et al.

LANCET CHILD & ADOLESCENT HEALTH , vol.2, no.7, pp.495-504, 2018 (SCI-Expanded)

41. Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizures

Franz D. N., Lawson J. A., Yapici Z., Brandt C., Kohrman M. H., Wong M., et al.

EPILEPSIA , vol.59, no.6, pp.1188-1197, 2018 (SCI-Expanded)

42. Megalencephalic leukoencephalopathy with subcortical cysts Characterization of disease variants

Hamilton E. M. C., Tekturk P., Cialdella F., van Rappard D. F., Wolf N. I., Yalcinkaya C., et al.

NEUROLOGY , vol.90, no.16, 2018 (SCI-Expanded)

43. A case with CMTX1 disease showing transient ischemic-attack-like episodes

Aktan Z., Akcakaya N. H., Tekturk P., Deniz E., Koyuncu B., Yapici Z.

NEUROLOGIA I NEUROCHIRURGIA POLSKA , vol.52, no.2, pp.285-288, 2018 (SCI-Expanded)

44. Cerebral Palsy and Genetics

Akcakaya N. H., Yapici Z., ÖZBEK U.

TURKISH JOURNAL OF NEUROLOGY , vol.24, no.1, pp.1-2, 2018 (ESCI)

45. Pallidal Stimulation in an 11-Year-Old Boy with Treatment-Resistant Tourette Syndrome

Kilincaslan A., Aydin S., Kok B. E., Akcakaya H., Yapici Z.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY , vol.27, no.7, pp.673-674, 2017 (SCI-Expanded)

46. De novo 8p23.1 deletion in a patient with absence epilepsy

Akcakaya N. H., Capan O. Y., Schulz H., Sander T., ÇAĞLAYAN S. H., Yapici Z.

EPILEPTIC DISORDERS , vol.19, no.2, pp.217-221, 2017 (SCI-Expanded)

47. Beneficial Effects of Everolimus on Autism and Attention-Deficit/Hyperactivity Disorder Symptoms in a Group of Patients with Tuberous Sclerosis Complex

Kilincaslan A., KOK B. E., Tekturk P., Yalcinkaya C., Ozkara C., Yapici Z.

Journal of Child and Adolescent Psychopharmacology , vol.27, no.4, pp.383-388, 2017 (SCI-Expanded)

48. Clinical and genetic features of PKAN patients in a tertiary centre in Turkey

AKÇAKAYA N., Iseri S. A., BILIR B., BATTALOGLU E., TEKTURK P., GULTEKIN M. H., et al.

CLINICAL NEUROLOGY AND NEUROSURGERY , pp.34-42, 2017 (SCI-Expanded) Sustainable Development

49. Idiopathic Intracranial Hypertension: Diagnosis and Therapeutic Approach

Akcakaya N. H., Akcakaya M. O., Sencer A., Yapici Z.

TURKISH JOURNAL OF NEUROLOGY , vol.23, no.2, pp.43-50, 2017 (ESCI) Sustainable Development

50. EEG Findings in Patients with Rett Syndrome

Ayta S., Oge A. E., Gurses C., Yapici Z., Eraksoy M.

EPILEPSI , vol.23, no.2, pp.63-71, 2017 (ESCI)

51. Atypical enterovirus encephalitis causing behavioral changes and autism-like clinical manifestations: case report

Akcakaya N. H., Tekturk P., Cagatay A., TUR E. K., Yapici Z.

ACTA NEUROLOGICA BELGICA , no.4, pp.679-681, 2016 (SCI-Expanded) Sustainable Development

52. Psychiatric Symptoms in Childhood Wilson's Disease: Case Reports

Demirkaya S. K., Yapici Z.

MEANDROS MEDICAL AND DENTAL JOURNAL , vol.17, no.3, pp.153-156, 2016 (ESCI)

53. Eyelid myoclonic status epilepticus: A rare phenotype in spinal muscular atrophy with progressive myoclonic epilepsy associated with ASAH1 gene mutation

Akarsu E. O., Tekturk P., Yapici Z., Tepgec F., Uyguner Z. O., Baykan B.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY , vol.42, pp.49-51, 2016 (SCI-Expanded)

54. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study

French J. A., Lawson J. A., Yapici Z., Ikeda H., Polster T., Nobbout R., et al.

LANCET , vol.388, no.10056, pp.2153-2163, 2016 (SCI-Expanded)

55. The effect of transcranial direct current stimulation on seizure frequency of patients with mesial temporal lobe epilepsy with hippocampal sclerosis

Tekturk P., Erdogan E. T., Kurt A., Vanli-yavuz E. N., Ekizoglu E., Kocagoncu E., et al.

CLINICAL NEUROLOGY AND NEUROSURGERY , vol.149, pp.27-32, 2016 (SCI-Expanded)

56. **A novel gene mutation in PANK2 in a patient with severe jaw-opening dystonia**

Yapici Z., Akcakaya N. H., Tekturk P., Iseri S. A., Ozbek U.

BRAIN & DEVELOPMENT , no.8, pp.755-758, 2016 (SCI-Expanded) Sustainable Development

57. ADJUNCTIVE EVEROLIMUS THERAPY FOR THE TREATMENT OF REFRACTORY SEIZURES IN PEOPLE WITH TUBEROUS SCLEROSIS COMPLEX

De Vries P. J., FRANZ D. N., LAWSON J. A., Yapici Z., POLSTER T., NABBOUT R., et al.

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH , vol.60, no.9, pp.839, 2016 (SSCI) Sustainable Development

58. Mutation in ATG5 reduces autophagy and leads to ataxia with developmental delay

KIM M., SANDFORD E., GATICA D., QIU Y., LIU X., ZHENG Y., et al.

ELIFE , vol.5, 2016 (SCI-Expanded) Sustainable Development

59. A role of autophagy in spinocerebellar ataxiaRare exception or general principle?

Burmeister M., Lee J., Schulman B. A., Yapici Z., TOLUN A., Juhasz G., et al.

AUTOPHAGY , vol.12, no.7, pp.1208-1209, 2016 (SCI-Expanded)

60. L-2-Hydroxyglutaric Aciduria: Report of Four Turkish Patients from the Same Family

Yalcin A. D., Tekturk P., Yapici Z.

JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH , vol.33, no.3, pp.494-500, 2016 (SCI-Expanded)

61. A case of hyperkinetic movement disorder associated with LGI1 antibodies

Erer-Ozbek S., Yapici Z., Tuzun E., Giris M., Duran S., Taskapilioglu O., et al.

TURKISH JOURNAL OF PEDIATRICS , vol.57, no.5, pp.514-517, 2015 (SCI-Expanded)

62. Abnormal Red Cell Structure and Function in Neuroacanthocytosis

CLUITMANS J. C. A., TOMELLERI C., Yapici Z., DINKLA S., BOVEE-GEURTS P., CHOKKALINGAM V., et al.

PLOS ONE , vol.10, no.5, 2015 (SCI-Expanded)

63. Cerebrospinal fluid synaptic proteins as useful biomarkers in tyrosine hydroxylase deficiency

ORTEZ C., Duarte S. T., ORMAZABAL A., SERRANO M., PEREZ A., PONS R., et al.

MOLECULAR GENETICS AND METABOLISM , vol.114, no.1, pp.34-40, 2015 (SCI-Expanded)

64. Homozygous splice mutation in CWF19L1 in a Turkish family with recessive ataxia syndrome

BURNS R., MAJCZENKO K., XU J., PENG W., Yapici Z., DOWLING J. J., et al.

NEUROLOGY , vol.83, no.23, pp.2175-2182, 2014 (SCI-Expanded)

65. Granzyme B gene polymorphism associated with subacute sclerosing panencephalitis

Yentur S. P., Aydin H. N., Gurses C., Demirbilek V., KURU U., Uysal S., et al.

Neuropediatrics , vol.45, no.5, pp.309-313, 2014 (SCI-Expanded) Sustainable Development

66. Alterations of Red Cell Membrane Properties in Nneuroacanthocytosis

Siegl C., Hamminger P., Jank H., Ahting U., Bader B., Danek A., et al.

PLOS ONE , vol.8, no.10, 2013 (SCI-Expanded)

67. Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32

STEFFENS M., LEU C., RUPPERT A., ZARA F., STRIANO P., ROBBIANO A., et al.

HUMAN MOLECULAR GENETICS , vol.21, no.24, pp.5359-5372, 2012 (SCI-Expanded)

68. The Prevalence of Multiple Sclerosis in the North Caucasus Region of Turkey: Door-to-Door Epidemiological Field Study

Alp R., Alp S. I., Planci Y., Yapici Z., Boru U. T.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.49, no.4, pp.272-275, 2012 (SCI-Expanded) Sustainable Development

69. A case with hyperkinetic frontal lobe epilepsy presenting as a psychiatric disturbance

Elmi H., Kilincaslan A., Ozturk M., Yapici Z.

TURKISH JOURNAL OF PEDIATRICS , vol.53, no.5, pp.574-578, 2011 (SCI-Expanded)

70. An association analysis at 2q36 reveals a new candidate susceptibility gene for juvenile absence epilepsy and/or absence seizures associated with generalized tonic-clonic seizures

Yalcin O., Baykan B., Agan K., Yapici Z., Yalcin D., Dizdarer G., et al.

EPILEPSIA , vol.52, no.5, pp.975-983, 2011 (SCI-Expanded)

71. Use of the International Classification of Headache Disorders, Second Edition, criteria in the diagnosis of primary headache in schoolchildren: Epidemiology study from eastern Turkey

Alp R., Alp S. I., Palanci Y., Sur H., Boru U. T., Ozge A., et al.

CEPHALALGIA , vol.30, no.7, pp.868-877, 2010 (SCI-Expanded) Sustainable Development

72. An Overview of L-2-Hydroxyglutarate Dehydrogenase Gene (L2HGDH) Variants: A Genotype-Phenotype Study

Steenweg M. E., Jakobs C., Errami A., van Dooren S. J. M., Adeva Bartolome M. T., Aerssens P., et al.

HUMAN MUTATION , vol.31, no.4, pp.380-390, 2010 (SCI-Expanded)

73. Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance

Dibbens L. M., Mullen S., Helbig I., Mefford H. C., Bayly M. A., Bellows S., et al.

HUMAN MOLECULAR GENETICS , vol.18, no.19, pp.3626-3631, 2009 (SCI-Expanded)

74. L-2-Hydroxyglutaric Aciduria: Pattern of MR Imaging Abnormalities in 56 Patients

Steenweg M. E., Salomons G. S., Yapici Z., Uziel G., Scalais E., Zafeiriou D. I., et al.

RADIOLOGY , vol.251, no.3, pp.856-865, 2009 (SCI-Expanded)

75. Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients

Akman-Demir G., Tuzun E., Jarius S., Icoz S., Kurtuncu M., Waters P., et al.

JOURNAL OF NEUROIMMUNOLOGY , vol.203, no.2, pp.184, 2008 (SCI-Expanded)

76. CD46 expression is decreased in subacute sclerosing panencephalitis patients

Yentur S. P., Gurses C., Demirbilek V., Uysal S., Yilmaz G., Yapici Z., et al.

JOURNAL OF NEUROIMMUNOLOGY , vol.203, no.2, pp.201, 2008 (SCI-Expanded)

77. Paroxysmal non-kinesigenic and hypnogenic dyskinesia associated with Streptococcal infection

Senbil N., Yapici Z., Gurer Y. K. Y.

PEDIATRICS INTERNATIONAL , vol.50, no.2, pp.255-256, 2008 (SCI-Expanded)

78. Incontinentia pigmenti mimicking a herpes simplex virus infection in the newborn

Okan F., Yapici Z., Bulbul A.

CHILDS NERVOUS SYSTEM , vol.24, no.1, pp.149-151, 2008 (SCI-Expanded)

79. Analgesia in preterm newborns: the comparative effects of sucrose and glucose.

Okan F., Coban A., Ince Z., Yapici Z., Can G.

European journal of pediatrics , vol.166, no.10, pp.1017-24, 2007 (SCI-Expanded) Sustainable Development

80. Neurological aspects of tuberous sclerosis in relation to MRI/MR spectroscopy findings in children with epilepsy

Yapici Z., Doertcan N., Baykan B., Okan F., Dincer A., Baykal C., et al.

NEUROLOGICAL RESEARCH , vol.29, no.5, pp.449-454, 2007 (SCI-Expanded)

81. High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis

YAPICI Z., Tuezuen E., ALTUNAYOGLU V., ERDOGAN A., ERAKSOY M.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , vol.117, no.11, pp.1505-1512, 2007 (SCI-Expanded)

82. Subacute sclerosing panencephalitis presenting with Balint's syndrome

Yapici Z.

BRAIN & DEVELOPMENT , vol.28, no.6, pp.398-400, 2006 (SCI-Expanded)

83. Worster-Drought syndrome (congenital bilateral perisylvian syndrome) with posterior pituitary ectopia, pituitary hypoplasia, empty sella and panhypopituitarism: A patient report

Bas F., Darendeliler F. F., Yapıcı Z., Gökalp S., Bundak R., Sakai N., et al.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.19, no.4, pp.535-540, 2006 (SCI-Expanded) Sustainable Development

84. Subacute sclerosing panencephalitis surveillance study in Istanbul

Onal A. E., Gürses C., Direskeneli G., Yılmaz G., Demirbilek V., Yentur S. P., et al.

BRAIN & DEVELOPMENT , vol.28, no.3, pp.183-189, 2006 (SCI-Expanded) Sustainable Development

85. Alterations in cell-mediated immune response in subacute sclerosing panencephalitis.

Yendur S. P., Gurses C., Demirbilek V., Yilmaz G., Onal A., Yapici Z., et al.

Journal of neuroimmunology , vol.170, pp.179-85, 2005 (SCI-Expanded) Sustainable Development

86. Çocukluk Çağı Baş ağrılarının Sınıflandırılması ve Depresyon, Anksiyete, Benlik Saygısı Ölçeklerinin Değerlendirilmesi

KOCASOY ORHAN E., Başgül S., YAPICI Z., Ş. Üneri Ö., ERAKSOY M.

Türk Nöroloji Derneği Dergisi , no.11, pp.605-610, 2005 (Peer-Reviewed Journal)

87. Elevated interleukin-12 and CXCL10 in subacute sclerosing panencephalitis

Saruhan-Direskeneli G., Gurses C., Demirbilek V., Yentur S. P., Yilmaz G., Onal E. Z., et al.

CYTOKINE , vol.32, no.2, pp.104-110, 2005 (SCI-Expanded) Sustainable Development

Papers Presented at Peer-Reviewed Scientific Conferences 29

1. İVİG Tedavisinin Uykuda Elektriksel Status Epileptikus Hastalarındaki İmmün Cevap ile İlişkisi.

Koral G., Soylu S., Topaloğlu P., Emekli A. S., Karaaslan Z., Yüceer Korkmaz H., et al.

13. Klinik Nöroimmünoloji Sempozyumu, Antalya, Turkey, 13 - 18 May 2024, (Unpublished)

2. Mitokondriyal-Membran Proteini İlişkili Nörodejenerasyona Neden Olan C19orf12 Geni 5’UTR Varyantının İn Siliko Analizleri

Kılıç M., Salman B., Süsgün S., Yücesan E., Uğur İşeri S. A., Yapıcı Obuz Z.

1. Nörogenetik ve Nörometabolizma Kongresi, İstanbul, Turkey, 9 - 11 May 2024, (Unpublished)

3. Multiple Rating Scales in 17 patients with Mitochondrial-membrane Protein Associated Neurodegeneration

SAYMAN C., ÇAPAN N., TOPALOĞLU P., UĞUR İŞERİ S. A., ÖZDEMİR S., BASLO M. B., et al.

17th Congress of the European Forum for Research in Rehabilitation, 02 November 2023, (Full Text)

4. Çocukluk Yaş Başlangıçlı Demiyelinizan Hastalıklarda Klinik-demografik Özellikler Ve Anti-MOG (Myelin Oligodendrosit Glikoprotein) Antikorlarının Prognoz Üzerindeki Etkilerinin Belirlenmesi

DUMAN İLKİ C., GÜNDÜZ T., TOPALOĞLU P., YAPICI Z., KÜRTÜNCÜ M., ERAKSOY M.

54. Ulusal Nöroloji Kongresi, Turkey, 30 November - 06 December 2018, (Summary Text)

5. Impact of Mutation Status on Seizure Outcomes in Patients with Tuberous Sclerosis Complex (TSC) Treated in the EXIST-3 Study

Yapici Z., Franz D., Lawson J., Ikeda H., Polster T., Nabbout R., et al.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 21 - 27 April 2018, vol.90, (Summary Text)

6. Efficacy and Safety of Everolimus Based on Prior and Concomitant Antiepileptic Drugs in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures: A Subanalysis of the Phase 3 EXIST-3 Study

Franz D., Lawson J., Yapici Z., Ikeda H., Polster T., Nabbout R., et al.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 21 - 27 April 2018, vol.90, (Summary Text)

7. NEDENİ BELİRLENEMEYEN EPİLEPTİK ENSEFALOPATİLERDE OTOİMMUN ANTİKORLARIN ARAŞTIRILMASI

Tektürk P., Baykal B., Erdağ E., Sezgin M., Küçükali C. İ., Yapıcı Z., et al.

53. Ulusal Nöroloji Kongresi, Antalya, Turkey, 24 - 30 November 2017, pp.13, (Summary Text)

8. 32 novel pathogenic sequence variants in 253 DMD/BMD patients from Turkey

Toksoy G., Agayev A., Bagirova G., Tekçe H., YAPICI Z., KAYSERİLİ KARABEY H., et al.

. European Human Genetics Conference, May 27-30, 2017, Copenhagen, Denmark., 27 - 30 May 2017, (Summary Text)

9. DİSTONİK STATUS İLE SEYREDEN SUBAKUT SKLEROZAN PANENSEFALİT OLGUSU

Sezgin M., Topaloğlu P., Taşkın A., Yapıcı Obuz Z.

52. ULUSAL NÖROLOJİ KONGRESİ , Antalya, Turkey, 25 November - 01 December 2016, pp.88-89, (Summary Text)

10. Adjunctive Everolimus Therapy for the Treatment of Refractory Seizures Associated with Tuberous Sclerosis Complex: Results from a Randomized, Placebo-Controlled, Phase 3 Trial

FRENCH J. A., LAWSON J. A., Yapici Z., Polster T., NABBOUT R., CURATOLO P., et al.

141st Annual Meeting of the American-Neurological-Association, Maryland, United States Of America, 16 - 18 October 2016, vol.80, (Summary Text)

11. Adjunctive everolimus therapy for the treatment of refractory seizures associated with tuberous sclerosis complex: Results from a randomized, placebo-controlled, phase 3 trial

FRENCH J., LAWSON J. A., Yapici Z., POLSTER T., NABBOUT R., CURATOLO P., et al.

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Canada, 15 - 21 April 2016, vol.87, (Summary Text)

29. Subakut Sklerozan Panensefalit Hastalarında Staphylococcus aureus SAC ve Copolymer 1 COP 1 Uyarısı ile Gelişen Proliferasyon ve Sitokin Yanıtı

YENTÜR S. P., GÜRSES R. C., DEMİRBİLEK A. V., UYSAL S., ÇELİK G., ÇOKAR A. Ö., et al.

XVIII. Ulusal İmmünoloji Kongresi, Bursa, Bursa, Turkey, 7 - 10 September 2005, (Summary Text)

Books 3

Metrics

Publication

119

Publication (WoS)

Publication (Scopus)

Citation (WoS)

1208

H-Index (WoS)

Citation (Scopus)

1340

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Project

Open Access

UN Sustainable Development Goals

Publications & Works